"Disclaimer: Pursuant to an agreement between MAPH and InMedPharmaceuticals., we were hired for a period beginning February 24 2017 and ending April 24, 2017 to publicly disseminate information about (IMLFF) including on the Website and other media including Facebook and Twitter. We are being paid $40,000 (CASH) for and were paid “250,000” shares of restricted common shares of InMed Pharmaceuticals."
...I figure it's responsible to share this tidbit from the bottom of the article. Anyone know what catalysts they are expecting by year's end?
News 
Market Data 
Discover 
